Kbc Group Nv Avid Bioservices, Inc. Transaction History

Kbc Group Nv

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Feb 15, 2024	SELL	$9.4 - $14.04 $17,408 - $26,002	-1,852 Reduced 40.34%	2,739 $26,000
Q2 2023 Feb 15, 2024	SELL	$12.96 - $20.93 $10,277 - $16,597	-793 Reduced 14.73%	4,591 $64,000
Q2 2023 Jul 28, 2023	SELL	$12.96 - $20.93 $10,277 - $16,597	-793 Reduced 14.73%	4,591 $64,000
Q3 2022 Feb 15, 2024	BUY	$15.33 - $20.36 $82,536 - $109,618	5,384 New	5,384 $103,000
Q2 2022 Feb 14, 2024	BUY	$11.63 - $21.55 $62,615 - $116,025	5,384 New	5,384 $82,000
Q2 2022 Jul 26, 2022	BUY	$11.63 - $21.55 $62,615 - $116,025	5,384 New	5,384 $82,000

209

67.1M

216K

4.6K

Ticker CDMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,167,500
Market Cap $776M
Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

Stay updated on Kbc Group Nv with notifications on news.